Sign In
Buy CI
$279.05
-8.61 (-2.99%)
At Close: Jul 31, 2026
Cigna Profits Hit $1.5 Billion Despite Higher Costs
06:30am, Thursday, 31'st Jul 2025
The Cigna Group reported a second quarter profit of $1.5 billion as its Evernorth health service business performs well and despite rising costs in its employer health benefits business.
Cigna beats profit estimate on robust health services growth
06:09am, Thursday, 31'st Jul 2025
Cigna beat Wall Street estimate for second-quarter profit on Thursday, helped by strength in its pharmacy benefit management business.
The Cigna Group Reports Strong Second Quarter 2025 Results, Reaffirms 2025 Adjusted EPS Outlook
06:00am, Thursday, 31'st Jul 2025
Total revenues for the second quarter 2025 increased 11% to $67.2 billion Shareholders' net income for the second quarter 2025 was $1.5 billion, or $5.71 per share Adjusted income from operations1 for
Cigna to Report Q2 Earnings: Can Evernorth Offset Healthcare Weakness?
12:36pm, Wednesday, 30'th Jul 2025
CI's Q2 results are likely to hinge on Evernorth's growth as core healthcare revenues and premiums face steep declines.
Evercore ISI's Umer Raffat on finding value in the beaten-down health care sector
02:06pm, Monday, 28'th Jul 2025
Umer Raffat, Evercore ISI senior analyst, joins 'The Exchange' to discuss if there's a turnaround coming for the health care sector.
3 Dividend Growth Stocks That Will Deliver Meaty Returns After 5 Years
01:38pm, Monday, 28'th Jul 2025
Sufficient earnings growth to continually increase dividends at a comfortably low payout ratio that also accommodates expansion capex is an excellent signal for strong upside potential.
Centene, Cigna, Others Drop As Molina's Results Rattle Sector
02:12pm, Thursday, 24'th Jul 2025
Molina Healthcare Inc. MOH missed Wall Street expectations in its second-quarter earnings report Wednesday, triggering a selloff across the healthcare insurance sector.
Cigna (CI) Reports Next Week: Wall Street Expects Earnings Growth
11:01am, Thursday, 24'th Jul 2025
Cigna (CI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Cigna Group Declares Quarterly Dividend
04:33pm, Tuesday, 22'nd Jul 2025
BLOOMFIELD, Conn. , July 22, 2025 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.51 per share of its common stock, payable on September 18,
10 Undervalued Dividend Growth Stocks: July 2025
09:00am, Monday, 21'st Jul 2025
I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate and anothe
Most Managed Care Insurers Expected To See Q2 2025 Drops In Revenue, Net Income
07:10am, Thursday, 17'th Jul 2025
A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecas
Why Cigna (CI) is a Top Dividend Stock for Your Portfolio
12:45pm, Wednesday, 16'th Jul 2025
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cigna (CI) have what it takes?
Cigna Group: Is The Value Real Or Are Investors Just Stuck In Neutral?
09:21am, Tuesday, 15'th Jul 2025
The Cigna Group's risk/reward is balanced after a rebound; I rate it Hold—worth keeping if owned, but not a compelling buy right now. The Evernorth pharmacy benefits arm drives growth, but regulator
Cigna: Price Pullback Is A Great Opportunity
04:00pm, Sunday, 13'th Jul 2025
Cigna trades at a significant discount to the S&P 500, offering a higher yield and faster dividend growth, making it attractive for total return investors. CI's robust earnings growth is fueled by its
Don't Miss Out On These 3 Dirt-Cheap SWANs
07:00am, Saturday, 12'th Jul 2025
We prefer to buy and hold stocks with a significant margin of safety. Today, we're highlighting a global tech and e-commerce juggernaut, the leading life sciences REIT, and a major managed healthcare
